The Asthma Options Paradox
Can ICER Fix What’s Broken?
ICER’s Message of Hopelessness
Health Plan Barriers & Migraine Are a Losing Combination
FDA Gives Final Word on Interchangeable Biosimilars
Cardiovascular Summit Spotlights Stories of Access Barriers, Risk and Heart Health
UK Study Reinforces Need for Personalized Treatment Plans
FDA to Tweak Naming System for Biological Medicines
U.S. is Missing the Mark on Hepatitis C Elimination
CMS Limits “Co-Pay Surprise” for Obamacare Patients
